MSB 4.12% $1.40 mesoblast limited

Ann: FDA Clears IND for Remestemcel Use in COVID-19 ARDS Patients, page-24

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 8,320 Posts.
    lightbulb Created with Sketch. 805
    In conjunction with kingtups request, does this mean we have been cleared to *investigate* remestemcel? So trials can begin? Thanks
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.40
Change
-0.060(4.12%)
Mkt cap ! $1.598B
Open High Low Value Volume
$1.43 $1.43 $1.39 $2.231M 1.592M

Buyers (Bids)

No. Vol. Price($)
1 211 $1.40
 

Sellers (Offers)

Price($) Vol. No.
$1.40 67925 17
View Market Depth
Last trade - 12.33pm 16/10/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.